ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999

Litton Awarded $342,618 For Frederick Fee

February 21, 1975

In Brief: Home Health Care Cost Effectiveness Data Sought Through Community Based Programs

May 20, 1977